Comment on "Ensuring the Efficacy and Safety of Approved Medications ".
作者信息
Oppenheimer J, Casale Thomas B, Tanimoto Sarina
机构信息
UMDNJ Rutgers University School of Medicine, Newark, New Jersey, USA.
Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
出版信息
J Med Toxicol. 2024 Jul 27;20(3):330-331. doi: 10.1007/s13181-024-01005-0. Epub 2024 May 2.
Abstract
摘要
相似文献
1
Comment on "Ensuring the Efficacy and Safety of Approved Medications ".
J Med Toxicol. 2024 Jul 27;20(3):330-331. doi: 10.1007/s13181-024-01005-0. Epub 2024 May 2.
2
In Response to "Comment on Ensuring the Efficacy and Safety of Approved Medications".
J Med Toxicol. 2024 Jul 11;20(3):332-333. doi: 10.1007/s13181-024-01006-z. Epub 2024 May 3.
3
Premarketing studies in the drug approval process: understanding their limitations regarding the assessment of drug safety.
Clin Ther. 1998;20 Suppl C:C12-9. doi: 10.1016/s0149-2918(98)80003-9.
4
Safety concerns at the FDA.
Lancet. 2005;365(9461):727-8. doi: 10.1016/S0140-6736(05)17994-X.
5
Off-label use of approved drugs.
Chest. 1999 Sep;116(3):589-91. doi: 10.1378/chest.116.3.589-a.
6
Inadequate and delayed characterization of cutaneous reactions for US Food and Drug Administration-approved oncologic drugs from 2011-2020 leading to medication discontinuation.
J Am Acad Dermatol. 2021 Nov;85(5):1351-1352. doi: 10.1016/j.jaad.2020.10.047. Epub 2020 Oct 23.
7
FDA-Approved Drugs to Treat ADHD.
J Psychosoc Nurs Ment Health Serv. 2018 Mar 1;56(3):13-14. doi: 10.3928/02793695-20180207-79.
8
FDA-Approved Drugs to Treat ADHD.
J Psychosoc Nurs Ment Health Serv. 2017 Mar 1;55(3):17-18. doi: 10.3928/02793695-20170126-79.
9
Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled Trials.
Mayo Clin Proc. 2019 Jan;94(1):74-83. doi: 10.1016/j.mayocp.2018.07.027.
10
The Trade-off Between Speed and Safety in Drug Approvals.
JAMA Oncol. 2017 Nov 1;3(11):1465-1466. doi: 10.1001/jamaoncol.2016.3337.
本文引用的文献
1
Ensuring the Efficacy and Safety of Approved Medications.
J Med Toxicol. 2024 Apr;20(2):81-83. doi: 10.1007/s13181-024-00998-y. Epub 2024 Feb 23.
2
Adult pharmacokinetics of self-administration of epinephrine nasal spray 2.0 mg versus manual intramuscular epinephrine 0.3 mg by health care provider.
J Allergy Clin Immunol Pract. 2024 Feb;12(2):500-502.e1. doi: 10.1016/j.jaip.2023.11.006. Epub 2023 Nov 10.
3
Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection.
J Allergy Clin Immunol. 2023 Dec;152(6):1587-1596. doi: 10.1016/j.jaci.2023.08.007. Epub 2023 Aug 19.
4
Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: An integrated analysis.
Ann Allergy Asthma Immunol. 2023 Apr;130(4):508-514.e1. doi: 10.1016/j.anai.2022.10.024. Epub 2022 Nov 2.
5
Epinephrine in the Management of Anaphylaxis.
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1186-1195. doi: 10.1016/j.jaip.2019.12.015.
6
Anaphylaxis--a practice parameter update 2015.
Ann Allergy Asthma Immunol. 2015 Nov;115(5):341-84. doi: 10.1016/j.anai.2015.07.019.
7
Anaphylaxis in children: current understanding and key issues in diagnosis and treatment.
Curr Allergy Asthma Rep. 2012 Dec;12(6):641-9. doi: 10.1007/s11882-012-0284-1.
8
Anaphylaxis.
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S161-81. doi: 10.1016/j.jaci.2009.12.981.
9
Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock.
Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD006312. doi: 10.1002/14651858.CD006312.pub2.
10
Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse.
Anaesth Intensive Care. 1986 Feb;14(1):17-21. doi: 10.1177/0310057X8601400105.
Zotero 插件